Summary of study on chronic GHRH treatment Overall, it appears that once-daily GHRH injections can stimulate the desired increases in GH and IGF-I and

result in significant increases in LBM and declines in fat mass, although these results are www.selleckchem.com/products/brefeldin-a.html tempered by estrogen status in women. Alone, however, they do not support an indication for treatment unless these increases induce meaningful changes in muscle mass and functional capacity and other outcome measures. While GHRH treatment produced a single large burst of GH secretion immediately Inhibitors,research,lifescience,medical following each evening injection, a “youthful” nighttime pulsatile GH secretion pattern was not restored. This increase in overall GH and IGF-I levels may suffice for some effects mediated

through GH Inhibitors,research,lifescience,medical and IGF-I (eg, changes in body composition and possibly improvements in cognitive function), but it is far from a restoration of nighttime pulsatile GH secretion, which may be required to support any possible beneficial effects on sleep quality. For this, a sustained-release formulation or an analog with a duration of action Inhibitors,research,lifescience,medical of at least 8 h will be needed. It must be emphasized that these conclusions regarding the effects of GHRH treatment are tentative, as more Inhibitors,research,lifescience,medical definitive results will not be available until both studies are completed and analyzed. Conclusions Our preliminary results show that once-daily evening subcutaneous injections of GHRH are well tolerated and can increase 24-h GH secretion, boost Inhibitors,research,lifescience,medical circulating levels of IGF-I, and improve body composition in older patients. Preliminary analyses also suggest beneficial effects on physical and cognitive performance. These findings, while encouraging further study, are far from the type of results that can support use of GHRH to “treat” aging.1,91 As aging is not Dacomitinib a disease, drug therapy cannot

be encouraged until meaningful functional benefits are shown either in treatment or in the prevention of specific disorders associated with aging. The recent preliminary report of a multicenter European study showing that GH may accelerate recovery from hip fracture92 is an example of such a finding. Nevertheless, the observed beneficial effects of GHRH and its minimal side effects are encouraging and indicate that future work in this area is well worth pursuing with the hope of ultimately improving the overall health and quality of life of the seniors, who currently represent the fastestgrowing segment of our population.